New drug combo trial offers hope for aggressive breast cancer
Disease control
ENROLLING_BY_INVITATION
This study is testing whether adding the experimental drug HB0025 to standard chemotherapy works better for people with advanced triple-negative breast cancer who haven't had previous treatment for their advanced disease. Researchers will enroll 60 participants to measure how wel…
Phase: PHASE2 • Sponsor: Huabo Biopharm Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC